Key result
Macrotroponin results in stable but misleadingly elevated cTnI levels without myocardial injury.
Why the study?
High-sensitivity cardiac troponin assays are vulnerable to macrotroponin analytical interference, which can lead to misdiagnosis, unnecessary testing, and inappropriate management.
Recognizing macrotroponin interference through orthogonal testing and PEG precipitation is crucial to avoid misdiagnosis and unnecessary procedures in patients with isolated troponin elevation.
Answers are grounded in this paper and cite their sources.
Orthogonal testing for macrotroponin warranted in unexplained troponin elevations; leaves open standardized detection protocols across assays.
High-sensitivity cardiac troponin assays are susceptible to analytical interferences, including macrotroponin, an immunoglobulin-bound complex that may cause persistent, non-dynamic, and assay-dependent elevations. This paper describes the case of a 74-year-old woman with hypertension who presented with intermittent mild chest discomfort and exertional dyspnea and exhibited persistently elevated but stable cardiac troponin I concentrations over several months, in the absence of clinical, electrocardiographic, or imaging evidence of myocardial injury. Orthogonal testing revealed discordant results across different assay platforms, and polyethylene-glycol (PEG) precipitation resulted in a substantial signal reduction, confirming macrotroponin as the source of assay-dependent analytical interference. Recognizing this phenomenon is crucial to avoid misdiagnosis, unnecessary diagnostic procedures and inappropriate management in patients with isolated troponin elevation. In conclusion, this report provides evidence-based recommendations on the optimal diagnostic strategies and laboratory approaches to adopt in cases of suspected macrotroponin-mediated interference in high-sensitivity cardiac troponin assays.
No takes yet. Share an insight, caveat, or question.
Salvatici et al. (2026) studied this question. Macrotroponin led to stable but misleadingly elevated cardiac troponin I levels in a 74-year-old woman without myocardial injury, highlighting diagnostic challenges.
Synapse has enriched 10 related papers. Consider them for comparative context: